Brief: Renovorx Announces $10 Million At Market Private Placement
18/03/2026 12:37
March 18 (Reuters) - RenovoRx Inc RNXT.O: RENOVORX ANNOUNCES $10 MILLION AT MARKET PRIVATE PLACEMENT RENOVORX INC - TO ISSUE 10.6 MILLION SHARES AT $0.938 PER SHARE WITH 50% WARRANT COVERAGE Source text: ID:nGNXc9DY4L Further company coverage: RNXT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer